A Novel GVHD-Prophylaxis with Low-Dose Alemtuzumab in Allogeneic Sibling or Unrelated Donor Hematopoetic Cell Transplantation: The Feasibility of Deescalation-Reference-Cited by-同舟云学术

A Novel GVHD-Prophylaxis with Low-Dose Alemtuzumab in Allogeneic Sibling or Unrelated Donor Hematopoetic Cell Transplantation: The Feasibility of Deescalation

Published:2009-12 Issue:12 Volume:15 Page:1563-1570
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bertz Hartmut,Spyridonidis Alexandros,Wäsch Ralph,Grüllich Carsten,Egger Mathias,Finke Jürgen

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference32 articles.

1. Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin;Finke;Br J Haematol,2000

2. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection;Hale;Blood,1998

3. Allogeneic stem cell transplantation with T cell-depleted grafts for lymphoproliferative malignancies;Novitzky;Biol Blood Marrow Transplant,2007

4. The Campath-1 antigen (CD52);Hale;Tissue Antigens,1990

5. The CD52 antigen and development of the Campath antibodies;Hale;Cytotherapy,2001

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party;Bone Marrow Transplantation;2023-12-02

2. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients;Translational Autoimmunity;2023

3. Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD);Metabolites;2021-10-27

4. Long-Term Infectious and Noninfectious Outcomes of Monthly Alemtuzumab as a Calcineurin Inhibitor- and Steroid-Free Regimen for Pancreas Transplant Recipients;Canadian Journal of Infectious Diseases and Medical Microbiology;2020-10-10

5. Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2020-06-26